Overview

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Status:
RECRUITING
Trial end date:
2026-01-20
Target enrollment:
Participant gender:
Summary
Pediatric subjects aged 6-17 with biopsy confirmed cancer and imaging findings suspicious for pulmonary metastatic disease scheduled to undergo pulmonary metastasectomy via and open or minimally invasive approach.
Phase:
PHASE1
Details
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator:
On Target Laboratories, LLC
Treatments:
Pafolacianine